Fig. 5
From: VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy
Association analyses between VISTA and clinical features across multiple cancers. (a) Associations between VISTA expression and overall survival across human cancers. (b) Associations between VISTA expression and stage across human cancers. (c) Associations between VISTA expression and grade across human cancers. (d) Associations between VISTA expression and molecular subtypes across human cancers. (e) Associations between VISTA expression and immune subtypes across human cancers. TISIDB was used to generate associations between expression of VISTA and prognostic impact or pathological distribution across multiple cancers (TCGA tumor). Log rank test and spearman test, as well as Kruskal-Wallis test, were individually used to calculate the associations, and p value < 0.05 was considered statistically significant